GenomeWeb premium newsletter covering pharmacogenomics, personalized medicine, and companion diagnostics, including regulatory issues, payor trends, and more.
New York, NY
Joined November 2009
- Tweets1.2K
- Following250
- Followers917
- Likes0
At AMP Corporate Event, BioFire Dx, Cepheid Presentations Offer Early Look at MDx Pipelines bit.ly/1wUfDqa
Biocept Launches Blood-based Lung Cancer Dx to Guide Therapy in Patients Lacking Tissue Biopsy bit.ly/1wUfClQ
Protagen, Qiagen Collaborate to Advance Development of Protein-based CDx for Autoimmune Diseases bit.ly/1qn0FMG
Gilotrif Survival Data for Del19 and L858R Patients has Implications for Treatment, Research bit.ly/1BhGc07
Following Republican Election Gain, Detractors of FDA Lab Test Regulation Seize Chance for Support bit.ly/1uZvAzy
Report Finds More Personalized Rx on the Market, but Field Lacks 'Integrator' bit.ly/10S6ANy
Myriad Projects Stronger Revenue Growth in Second Half of FY2015 Driven by CDx, Prolaris bit.ly/1uxA28D
Drawing Lessons from US Gene Patent Cases, Canadian Hospital Focuses on Enabling NGS Testing bit.ly/1uwTVMP
Study IDs New Loci, Explains 5 Percent of Variation in Cholesterol-Lowering Effects of Statins bit.ly/1uwTVwr
After Health Canada Approval, Spartan Plans to Launch Point-of-Care CYP2C19 Dx via Pharmacy Pilots bit.ly/1tJahR1
Genome British Columbia Backs Regional Project to Study Benefits of Pharmacist-guided PGx Testing bit.ly/1tNwWN6
Arno's Onapristone Program Advancing in Castration-resistant Prostate Cancer, Gynecologic Tumors bit.ly/1tNwWwG
People in the News: Luis Gutierrez, Mara Aspinall, Greg Lucier, Valerie Palmieri bit.ly/1nQmaDT
NanoString Study Shows Prosigna Can Assess Breast Cancer Patients' Risk of Late, Distant Recurrence bit.ly/1DwniP2
Pharmacist Group Sees Value in Offering Assurex PGx Tests for Mental Health, Pain Rx Personalization bit.ly/1wA3PM1